ArticleCanadian journal of gastroenterology & hepatology2022

Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study.

Yiran Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.